Mortality risk of antipsychotic augmentation for adult depression

IMPORTANCE: Randomized controlled trials have demonstrated increased all-cause mortality in elderly patients with dementia treated with newer antipsychotics. It is unknown whether this risk generalizes to non-elderly adults using newer antipsychotics as augmentation treatment for depression. OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerhard, Tobias, Stroup, T. Scott, Correll, Christoph U., Setoguchi, Soko, Strom, Brian L., Huang, Cecilia, Tan, Zhiqiang, Crystal, Stephen, Olfson, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526884/
https://www.ncbi.nlm.nih.gov/pubmed/32997687
http://dx.doi.org/10.1371/journal.pone.0239206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526884/
https://www.ncbi.nlm.nih.gov/pubmed/32997687
http://dx.doi.org/10.1371/journal.pone.0239206

Ejemplares similares